The free dividend tracker to help you grow your wealth. Link your brokerage accounts and MerryDiv automatically syncs your holdings and dividends.
Data last updated: Jul 06, 2026
Dividend Yield: 0.21%
Annual Dividend: $0.11 per share
Payout Ratio: -5.9%
Ex-Dividend Date: 2026-04-28
Dividend Frequency: quarterly
Sector: Healthcare
Years of Dividend History: 32
Bayer AG is a global life sciences company spanning pharmaceuticals, consumer health, and crop science, with prescription drugs in cardiology and oncology alongside over-the-counter products and agricultural solutions. The Bayer AG dividend currently yields 0.21%, with a trailing annual dividend rate of $0.11 per share paid quarterly. The next ex-dividend date is April 28, 2026. At a beta of 0.83, BAYRY stock moves with less volatility than the broader market, which appeals to investors who prioritize price stability over high income.
Bayer AG pays out -5.9% of earnings as dividends, a payout ratio classified as conservative (below 40%). A negative payout ratio reflects a period of reported losses rather than earnings coverage, so the low absolute dollar amount of the dividend, $0.11 per share annually, is what keeps Bayer AG dividend safety intact for now. The most significant pressure factor is that the payout ratio is driven by negative earnings, meaning the dividend is not being covered by profits in the conventional sense.
Bayer AG dividend history shows a CAGR of -18.9% per year from 2007 to 2025. Per-share payments fell from $1.3592 at the start of the window to $0.0311 by 2025 (with 2026 partial year data showing $0.0321 so far, per Bayer AG dividend 2026 figures). The largest annual increase in the window was 54.2% in 2008, but the overall direction has been sharply downward, and the data also contains at least one year-over-year decline exceeding 5%.
BAYRY stock fits dividend investors who prioritize low volatility over income generation. The yield is low (below 2%), sitting at just 0.21% today, far below the 5-year average of 2.44%, which shows how much ground the payout has lost. Bayer AG operates across pharmaceuticals, consumer health, and crop science, giving it broad business diversification, but that has not translated into dividend growth. The trade-off is clear: an investor gets a large, globally diversified life sciences company with a beta of 0.83, but accepts a minimal yield and a dividend that has declined sharply over the past 18 years.
| Payment Date | Amount per Share |
|---|---|
| 2026-04-28 | $0.0321 |
| 2025-04-29 | $0.0311 |
| 2024-04-29 | $0.0294 |
| 2023-05-02 | $0.6602 |
| 2022-05-02 | $0.5258 |
| 2021-04-28 | $0.6041 |
| 2020-04-29 | $0.7626 |
| 2019-04-29 | $0.7823 |
| 2018-06-22 | $0.4162 |
| 2018-05-25 | $0.8131 |
| Year | Total Dividends |
|---|---|
| 2026 | $0.0321 |
| 2025 | $0.0311 |
| 2024 | $0.0294 |
| 2023 | $0.6602 |
| 2022 | $0.5258 |
Project income from BAYRY with the BAYRY dividend calculator or track your full portfolio with the dividend tracker.